[Postoperative hyperkinetic arrhythmias treated with amiodarone].
Twenty eight patients have been treated; 8 patients had atrial fibrillation (FA) and 20 supraventricular paroxysmal (SVPT) tachycardia. Both diseases followed interventions of major surgery. No patient had myocardial ischemia and/or damaged conduction system, took any heart-related drug, or showed any risk factor. The posologic plans was as follows: a) bolus i.v. (three minutes) with 2 Amiodarone vials and electrocardiographic monitoring, then b) 10-20 mg/kg/day for three days with electrocardiographic monitoring. Within 5 days, all patients attained the total recovery from SVPT; AF regressed during the bolus injection in 1 patient, on the first day in 5 patients, and on the third day in the remaining 2 patients. During the hospitalization no important side effects occurred, except for transient hypotension in three subjects. The 6 months follow up did not reveal signs of intolerance, either. Amiodarone thus showed to be useful and well tolerated in the treatment of post-surgical hyperkinetic arrhythmias in patients undergoing major surgery.
Politi
G
G
Istituto di Chirurgia Generale e Chirurgia Toracica, Università degli Studi di Milano.
Romanini
B
B
Tos
M
M
Pucci
C
C
Rescalli
S
S
Ferro
C
C
D000638:Amiodarone / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D004341:Drug Evaluation; D004562:Electrocardiography; D006801:Humans; D008991:Monitoring, Physiologic; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy; D013997:Time Factors
D000638:Amiodarone
Aritmie ipercinetiche insorte nel periodo postoperatorio trattate con amiodarone.